Press Release: Metabiomics : Prescient Medicine and Metabiomics Partner to Develop New Gastrointestinal Health Tests to Detect Polyps, Prevent Colon Cancer
CHICAGO, Sept. 18, 2018 /PRNewswire/ -- Prescient Medicine Holdings, LLC and Metabiomics Corp., have announced a joint venture to develop an innovative microbiome diagnostics platform for detecting precancerous colon polyps and diagnosing other types of gastrointestinal diseases including ...
Read full article »
Metabiomics develops non-invasive diagnostics for colon polyps and colon cancer based on an interrogation of the human gut microbiome.
Read more